AMPK regulates lipid accumulation in skeletal muscle cells through FTO-dependent demethylation of N6-methyladenosine

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Wu, Weiche ^a,b   Feng, Jie ^a,b   Jiang, Denghu ^a,b   Zhou, Xihong ^c   Jiang, Qin ^a,b   Cai, Min ^a,b   Wang, Xinxia ^a,b   Shan, Tizhong ^a,b   Wang, Yizhen ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Zhejiang Provincial Laboratory of Feed and Animal Nutrition   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALPHA KETOGLUTARATE DEPENDENT DIOXYGENASE FTO; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; N(6)-METHYLADENOSINE;

ANALOGS AND DERIVATIVES; ANIMAL; BIOLOGICAL MODEL; CELL LINE; DEMETHYLATION; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; SKELETAL MUSCLE CELL;

ADENOSINE; ALPHA-KETOGLUTARATE-DEPENDENT DIOXYGENASE FTO; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; DEMETHYLATION; GENE EXPRESSION; LIPID METABOLISM; MALE; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUSCLE FIBERS, SKELETAL; PHOSPHORYLATION; RNA, MESSENGER;

EID: 85011971584     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41606     Document Type: Article

References (57)

1. Whiting, D. R., Guariguata, L., Weil, C. &Shaw, J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical practice 94, 311-321 (2011).
2. Finucane, M. M. et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 91 million participants. The Lancet 377, 557-567 (2011).
3. Defronzo, R. A., Ferrannini, E., Sato, Y. &Felig, P. Synergistic Interaction between Exercise and Insulin on Peripheral Glucose-Uptake. J Clin Invest 68, 1468-1474 (1981).
4. Pan, D. A. et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983-988 (1997).
5. Goodpaster, B. H., Theriault, R., Watkins, S. C. &Kelley, D. E. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49, 467-472 (2000).
6. DeFronzo, R. A. Pathogenesis of type 2 diabetes mellitus. Med Clin N Am 88, 787-+ (2004).
7. Akhmedov, D. &Berdeaux, R. The effects of obesity on skeletal muscle regeneration. Frontiers in physiology 4, 371 (2013).
8. Hegarty, B. D., Cooney, G. J., Kraegen, E. W. &Furler, S. M. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51, 1477-1484 (2002).
9. He, J., Watkins, S. &Kelley, D. E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50, 817-823 (2001).
10. Badin, P. M. et al. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes 60, 1734-1742 (2011).
11. Haemmerle, G. et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734-737 (2006).
12. Nunes, P. M. et al. Increased intramyocellular lipids but unaltered in vivo mitochondrial oxidative phosphorylation in skeletal muscle of adipose triglyceride lipase-deficient mice. American journal of physiology. Endocrinology and metabolism 303, E71-81 (2012).
13. Haemmerle, G. et al. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 277, 4806-4815 (2002).
14. Collier, C. A., Bruce, C. R., Smith, A. C., Lopaschuk, G. &Dyck, D. J. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. American journal of physiology. Endocrinology and metabolism 291, E182-189 (2006).
15. Fujii, N. et al. Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 57, 2958-2966 (2008).
16. Kurth-Kraczek, E. J., Hirshman, M. F., Goodyear, L. J. &Winder, W. W. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48, 1667-1671 (1999).
17. Merrill, G. F., Kurth, E. J., Hardie, D. G. &Winder, W. W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. The American journal of physiology 273, E1107-1112 (1997).
18. O'Neill, H. M. et al. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. Diabetologia 57, 1693-1702 (2014).
19. Zong, H. H. et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. P Natl Acad Sci USA 99, 15983-15987 (2002).
20. Hardie, D. G., Ross, F. A. &Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature reviews. Molecular cell biology 13, 251-262 (2012).
21. Fu, Y., Dominissini, D., Rechavi, G. &He, C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nature reviews. Genetics 15, 293-306 (2014).
22. Wang, X., Zhu, L., Chen, J. &Wang, Y. mRNA m(6)A methylation downregulates adipogenesis in porcine adipocytes. Biochemical and biophysical research communications 459, 201-207 (2015).
23. Zhao, X. et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res 24, 1403-1419 (2014).
24. Liu, J. et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol 10, 93-95 (2014).
25. Ping, X. L. et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res 24, 177-189 (2014).
26. Jia, G. F. et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO (vol 7, pg 885, 2011). Nat Chem Biol 8, 1008-1008 (2012).
27. Zheng, G. Q. et al. ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility. Mol Cell 49, 18-29 (2013).
28. Spector, D. L. &Lamond, A. I. Nuclear speckles. Cold Spring Harbor perspectives in biology 3 (2011).
29. Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
30. Church, C. et al. Overexpression of Fto leads to increased food intake and results in obesity. Nature genetics 42, 1086-1092 (2010).
31. Fischer, J. et al. Inactivation of the Fto gene protects from obesity. Nature 458, 894-898 (2009).
32. Chen, J., Zhou, X., Wu, W., Wang, X. &Wang, Y. FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice. Journal of physiology and biochemistry 71, 405-413 (2015).
33. Zhou, X. et al. The beneficial effects of betaine on dysfunctional adipose tissue and N6-methyladenosine mRNA methylation requires the AMP-activated protein kinase alpha1 subunit. J Nutr Biochem 26, 1678-1684 (2015).
34. Birk, J. B. &Wojtaszewski, J. F. Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle. The Journal of physiology 577, 1021-1032 (2006).
35. Meex, R. C. R., Schrauwen, P. &Hesselink, M. K. C. Modulation of myocellular fat stores: lipid droplet dynamics in health and disease. Am J Physiol-Reg I 297, R913-R924 (2009).
36. Muoio, D. M. Intramuscular triacylglycerol and insulin resistance: Guilty as charged or wrongly accused? Bba-Mol Cell Biol L 1801, 281-288 (2010).
37. Goodpaster, B. H. &Kelley, D. E. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Current diabetes reports 2, 216-222 (2002).
38. Choi, C. S. et al. Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulinstimulated muscle glucose metabolism. Proc Natl Acad Sci USA 105, 19926-19931 (2008).
39. Chao, L. C. et al. Insulin Resistance and Altered Systemic Glucose Metabolism in Mice Lacking Nur77. Diabetes 58, 2788-2796 (2009).
40. Shan, T. Z., Zhang, P. P., Bi, P. P. &Kuang, S. H. Lkb1 Deletion Promotes Ectopic Lipid Accumulation in Muscle Progenitor Cells and Mature Muscles. J Cell Physiol 230, 1033-1041 (2015).
41. Steinberg, G. R. et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell metabolism 4, 465-474 (2006).
42. Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J. &Olefsky, J. M. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277-2285 (2006).
43. Steinberg, G. R. et al. Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase-dependent pathway that is impaired with obesity. Diabetes 58, 829-839 (2009).
44. Wilkes, J. J., Nguyen, M. T., Bandyopadhyay, G. K., Nelson, E. &Olefsky, J. M. Topiramate treatment causes skeletal muscle insulin sensitization and increased Acrp30 secretion in high-fat-fed male Wistar rats. American journal of physiology. Endocrinology and metabolism 289, E1015-1022 (2005).
45. Chen, W. L., Chen, Y. L., Chiang, Y. M., Wang, S. G. &Lee, H. M. Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARalpha/AMPK/FoxO1/ATGL pathway. Biochem Pharmacol 84, 522-531 (2012).
46. Liu, X., Yuan, H., Niu, Y., Niu, W. &Fu, L. The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice. Biochimica et biophysica acta 1822, 1716-1726 (2012).
47. Ahmadian, M. et al. Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype. Cell metabolism 13, 739-748 (2011).
48. Chen, J. P., Zhou, X. H., Wu, W. C., Wang, X. X. &Wang, Y. Z. FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice. J Physiol Biochem 71, 405-413 (2015).
49. Medina-Gomez, G., Gray, S. &Vidal-Puig, A. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public health nutrition 10, 1132-1137 (2007).
50. Wu, Z. D. et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3, 151-158 (1999).
51. Gerken, T. et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318, 1469-1472 (2007).
52. Bravard, A. et al. FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. Diabetes 60, 258-268 (2011).
53. Church, C. et al. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS genetics 5, e1000599 (2009).
54. Larder, R., Cheung, M. K., Tung, Y. C., Yeo, G. S. &Coll, A. P. Where to go with FTO? Trends in endocrinology and metabolism: TEM 22, 53-59 (2011).
55. Merkestein, M. et al. FTO influences adipogenesis by regulating mitotic clonal expansion. Nat Commun 6, 6792 (2015).
56. McMurray, F. et al. Pharmacological inhibition of FTO. Plos One 10, e0121829 (2015).
57. Zhang, J. L. et al. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in nonalcoholic fatty liver disease. Chinese Med J-Peking 127, 3771-3776 (2014).